Legal
Key facts
Pomerantz LLP announced a class action lawsuit has been filed against Capricor Therapeutics, Inc
Key facts
Capricor Therapeutics is identified as NASDAQ: CAPR
Key facts
Investors who purchased or otherwise acquired Capricor securities during the class period have until September 28,…
Atlas Watchline
Pomerantz LLP says a securities class action has been filed against Capricor Therapeutics and that investors…